ORIGINAL ARTICLE

Prognostic value of activated Akt expression in oral squamous cell carcinoma

J Lim¹, J-H Kim², J-Y Paeng³, M-J Kim³, S-D Hong¹, J-I Lee¹ and S-P Hong¹

¹ Department of Oral Pathology, Dental School, Dental Research Institute, Seoul National University, 28-2 Yongon-dong, Jongno-gu, Seoul 110-744, Korea
² Department of Dentistry, Pundang Jesaeng Hospital, Pundang-gu, Kyounggi-do 463-774, Korea
³ Department of Oral and Maxillofacial Surgery, Dental School, Seoul National University

Correspondence to:
Correspondence to:
Dr S-P Hong
Department of Oral Pathology, Dental School, Dental Research Institute, Seoul National University, 28-2 Yongon-dong, Jongno-gu, Seoul 110-744, Korea; zjon0224{at}snu.ac.kr

Background: Akt is a serine/threonine kinase that plays an important role in tumorigenesis and influences prognosis in several cancers. However, its importance in oral squamous cell carcinomas (OSCC) has not been elucidated.

Aim: To investigate the association between the expression of activated Akt, clinicopathological factors, and E-cadherin, PCNA (proliferating cell nuclear antigen), and VEGF (vascular endothelial growth factor) expression to verify the validity of Akt as a prognostic factor in OSCC.

Methods: Phosphorylated Akt (p-Akt), E-cadherin, PCNA, and VEGF expression were assessed immunohistochemically in 84 OSCCs. The results were analysed in relation to clinicopathological factors.

Results: p-Akt was expressed in 29 cases. It was significantly correlated with lymph node metastasis, TNM stage, and E-cadherin expression. Univariate analysis showed that p-Akt expression, E-cadherin expression, PCNA expression, differentiation, tumour size, lymph node metastasis, TNM stage, and recurrence correlated with prognosis. Multivariate analysis showed that p-Akt expression is an independent prognostic factor in patients with OSCC.

Conclusions: This study revealed that Akt activation is a significant prognostic indicator for OSCC and is correlated with E-cadherin expression. The inhibition of Akt is a possible molecular approach to the treatment of OSCC.

Abbreviations: LI, labelling index; OSCC, oral squamous cell carcinoma; PBS, phosphate buffered saline; p-Akt, phosphorylated Akt; PCNA, proliferating cell nuclear antigen; VEGF, vascular endothelial growth factor

Keywords: oral squamous cell carcinoma; Akt; E-cadherin; prognostic factor

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Burns, J. A., Li, Y., Cheney, C. A., Ou, Y., Franlin-Pfeifer, L. L., Kuklin, N., Zhang, Z.-Q. (2009). Choice of Fixative Is Crucial to Successful Immunohistochemical Detection of Phosphoproteins in Paraffin-embedded Tumor Tissues. J. Histochem. Cytochem. 57: 257-264 [Abstract] [Full Text]  
• Johnson, T. L., Lai, M. B., Lai, J. C. K., Bhushan, A. (2008). Inhibition of Cell Proliferation and MAP Kinase and Akt Pathways in Oral Squamous cell Carcinoma by Genistein and Biochanin A. Evid Based Complement Alternat Med 0: nen011v1-nen011 [Abstract] [Full Text]  
• Choe, M. S., Chen, Z., Klass, C. M., Zhang, X., Shin, D. M. (2007). Enhancement of Docetaxel-Induced Cytotoxicity by Blocking Epidermal Growth Factor Receptor and Cyclooxygenase-2 Pathways in Squamous Cell Carcinoma of the Head and Neck. Clin. Cancer Res. 13: 3015-3023 [Abstract] [Full Text]  
• Yu, Z., Weinberger, P. M., Sasaki, C., Egleston, B. L., Speier, W. F. IV, Haffty, B., Kowalski, D., Camp, R., Rimm, D., Vairaktaris, E., Burtness, B., Psyrri, A. (2007). Phosphorylation of Akt (Ser473) Predicts Poor Clinical Outcome in Oropharyngeal Squamous Cell Cancer. Cancer Epidemiol. Biomarkers Prev. 16: 553-558 [Abstract] [Full Text]